132 related articles for article (PubMed ID: 1835412)
21. Suppression of growth and dissemination in human pre-B leukemia cells by tumor necrosis factor-alpha in scid mice.
Yoshida N; Ishii E; Mohri S; Nagumo F; Yoshidomi S; Miyazaki S
Leuk Lymphoma; 1999 Mar; 33(1-2):107-18. PubMed ID: 10194127
[TBL] [Abstract][Full Text] [Related]
22. Long-term survival and proliferation of precursor-B acute lymphoblastic leukemia cells on human bone marrow stroma.
Bradstock K; Bianchi A; Makrynikola V; Filshie R; Gottlieb D
Leukemia; 1996 May; 10(5):813-20. PubMed ID: 8656676
[TBL] [Abstract][Full Text] [Related]
23. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
[TBL] [Abstract][Full Text] [Related]
24. Neuropeptide Y (NPY) synthesis in lymphoblasts and increased plasma NPY in pediatric B-cell precursor leukemia.
Kogner P; Ericsson A; Barbany G; Persson H; Theodorsson E; Björk O
Blood; 1992 Sep; 80(5):1324-9. PubMed ID: 1387563
[TBL] [Abstract][Full Text] [Related]
25. Transient erythroblastopenia of childhood with CD10, TdT, and cytoplasmic mu lymphocyte positivity in bone marrow.
Foot AB; Potter MN; Ropner JE; Wallington TB; Oakhill A
J Clin Pathol; 1990 Oct; 43(10):857-9. PubMed ID: 2146287
[TBL] [Abstract][Full Text] [Related]
26. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
[TBL] [Abstract][Full Text] [Related]
27. Significance of common acute lymphoblastic leukemia antigen (cALLA) positive cells in bone marrow of children off therapy in complete remission.
Self SE; Morgan S; Grush O; La Via MF
Hematol Oncol; 1990; 8(2):91-5. PubMed ID: 2140561
[TBL] [Abstract][Full Text] [Related]
28. Abnormal in vitro differentiation of clonogenic B-cells in common acute lymphoblastic leukemia in complete remission. A marker for minimal residual disease?
Bréard J; Mathé G; Consolini R
Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):47-50. PubMed ID: 2525967
[TBL] [Abstract][Full Text] [Related]
29. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H
Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461
[TBL] [Abstract][Full Text] [Related]
30. In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Manivel C; Arthur D; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Irvin JD; Myers DE; Gunther R
Blood; 1992 May; 79(9):2201-14. PubMed ID: 1373967
[TBL] [Abstract][Full Text] [Related]
31. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement.
Lin P; Jones D; Dorfman DM; Medeiros LJ
Am J Surg Pathol; 2000 Nov; 24(11):1480-90. PubMed ID: 11075849
[TBL] [Abstract][Full Text] [Related]
32. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
[TBL] [Abstract][Full Text] [Related]
33. The laminin-derived peptide YIGSR (Tyr-Ile-Gly-Ser-Arg) inhibits human pre-B leukaemic cell growth and dissemination to organs in SCID mice.
Yoshida N; Ishii E; Nomizu M; Yamada Y; Mohri S; Kinukawa N; Matsuzaki A; Oshima K; Hara T; Miyazaki S
Br J Cancer; 1999 Aug; 80(12):1898-904. PubMed ID: 10471037
[TBL] [Abstract][Full Text] [Related]
34. Persistence of self-renewing leukemia cell progenitors during remission in children with B-precursor acute lymphoblastic leukemia.
Estrov Z; Ouspenskaia MV; Felix EA; McClain KL; Lee MS; Harris D; Pinkel DP; Zipf TF
Leukemia; 1994 Jan; 8(1):46-52. PubMed ID: 8289497
[TBL] [Abstract][Full Text] [Related]
35. Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID mice.
Uckun FM; Waurzyniak BJ; Sensel MG; Chelstrom L; Crotty ML; Gaynon PS; Reaman GH
Leuk Lymphoma; 1998 Jul; 30(3-4):269-77. PubMed ID: 9713959
[TBL] [Abstract][Full Text] [Related]
36. Acute lymphoblastic leukemias from relapse engraft more rapidly in SCID mice.
Palucka AK; Scuderi R; Porwit A; Jeha S; Gruber A; Björkholm M; Beran M; Pisa P
Leukemia; 1996 Mar; 10(3):558-63. PubMed ID: 8642875
[TBL] [Abstract][Full Text] [Related]
37. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
[TBL] [Abstract][Full Text] [Related]
38. Subpopulations of CD10-positive cells in bone marrow of children with acute lymphoblastic leukemia off therapy.
Molica S; Dattilo A; Consarino C; Puzzonia P; Magro S
Am J Hematol; 1991 Jul; 37(3):213-4. PubMed ID: 1830453
[No Abstract] [Full Text] [Related]
39. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
Burnusuzov HA; Spasova MI; Murdjeva MA; Stoyanova AA; Mumdziev IN; Kaleva VI; Belcheva MI; Bosheva MN
Folia Med (Plovdiv); 2016 Mar; 58(1):28-35. PubMed ID: 27383875
[TBL] [Abstract][Full Text] [Related]
40. Terminal deoxynucleotidyl transferase and HLA-DR expression appear unrelated to prognosis of acute myeloid leukaemia.
Swirsky DM; Greaves MF; Gray RG; Rees JK
Br J Haematol; 1988 Oct; 70(2):193-8. PubMed ID: 2973345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
